Emcure Pharmaceuticals Ltd (EMCURE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039308,
    "name": "Emcure Pharma",
    "stock_name": "Emcure Pharma",
    "full_name": "Emcure Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/emcure-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,713.60",
    "chg": -16.3,
    "chgp": "-0.94%",
    "dir": -1,
    "prev_price": "1,729.90",
    "mcapval": "32,500.06 Cr",
    "mcap": "Small Cap",
    "scripcode": 544210,
    "symbol": "EMCURE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE168P01015",
    "curr_date": "Jun 11, 12:45 PM",
    "curr_time": "12:46 PM",
    "last_traded_at": "Jun 11, 12:45 PM IST",
    "bse_nse_vol": "83.33 k",
    "exc_status": "Active",
    "traded_date": "Jun 11, 2026",
    "traded_date_str": "2026 06 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/emcure-pharma-10039308-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Emcure Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-ltd-is-rated-hold-4046403",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EmcurePharmaceu_mojoScore_4046403.png",
        "date": "2026-06-11 10:10:57",
        "description": "Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 June 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4045987",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EmcurePharmaceu_technicaldot_4045987.png",
        "date": "2026-06-11 08:05:39",
        "description": "Emcure Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a slight dip in the daily price, the stock’s technical indicators reveal a complex interplay of signals that investors should carefully analyse amid a volatile market backdrop."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4040307",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EmcurePharmaceu_technicaldot_4040307.png",
        "date": "2026-06-09 08:05:51",
        "description": "Emcure Pharmaceuticals Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a recent day decline of 2.33%, the stock’s year-to-date return of 26.05% significantly outpaces the Sensex’s negative 13.72% over the same period, underscoring its relative strength amid broader market weakness."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-ltd-is-rated-hold-4024241",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EmcurePharmaceu_mojoScore_4024241.png",
        "date": "2026-05-31 10:10:42",
        "description": "Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Valuation Shifts Amidst Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-valuation-shifts-amidst-market-volatility-4009937",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EmcurePharmaceu_valuationdot_4009937.png",
        "date": "2026-05-25 08:02:02",
        "description": "Emcure Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, reflecting a recalibration of price attractiveness despite robust financial performance and market returns. This adjustment, coupled with a downgrade in its Mojo Grade from Buy to Hold, invites a closer examination of the company’s current market standing relative to its historical averages and peer group."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-ltd-is-rated-hold-4000693",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EmcurePharmaceu_mojoScore_4000693.png",
        "date": "2026-05-20 10:10:56",
        "description": "Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Valuation Shifts Signal Caution Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-valuation-shifts-signal-caution-amid-strong-returns-3997949",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EmcurePharmaceu_valuationdot_3997949.png",
        "date": "2026-05-19 08:03:05",
        "description": "Emcure Pharmaceuticals Ltd has experienced a notable change in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, prompting a reassessment of its price attractiveness amid sector peers and historical benchmarks. Despite strong operational metrics, the stock’s elevated price-to-earnings and price-to-book ratios suggest a cautious stance for investors evaluating entry or exit points."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Valuation Shifts Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-valuation-shifts-amid-market-volatility-3988564",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EmcurePharmaceu_valuationdot_3988564.png",
        "date": "2026-05-13 08:02:02",
        "description": "Emcure Pharmaceuticals Ltd has seen a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, despite delivering robust returns well above the Sensex benchmark. This recalibration in price attractiveness, driven by elevated price-to-earnings and price-to-book ratios, signals a critical juncture for investors assessing the stock’s future potential within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-ltd-is-rated-hold-3982715",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EmcurePharmaceu_mojoScore_3982715.png",
        "date": "2026-05-09 10:10:36",
        "description": "Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date view of its performance and prospects."
      }
    ],
    "total": 418,
    "sid": "10039308",
    "stock_news_url": "https://www.marketsmojo.com/news/emcure-pharmaceuticals-10039308"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "27-May-2026",
      "details": "Annual Secretarial Compliance Report for the Financial Year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "20-May-2026",
      "details": "Intimation of schedule of Analyst/ Investor Meeting on June 09 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "20-May-2026",
      "details": "Intimation of schedule of Analyst/ Investor Meeting on May 26 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Emcure Pharmaceuticals Ltd has declared <strong>30%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Emcure Pharmaceuticals Ltd is Rated Hold

2026-06-11 10:10:57

Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 June 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Emcure Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-06-11 08:05:39

Emcure Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a slight dip in the daily price, the stock’s technical indicators reveal a complex interplay of signals that investors should carefully analyse amid a volatile market backdrop.

Read full news article

Emcure Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-09 08:05:51

Emcure Pharmaceuticals Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a recent day decline of 2.33%, the stock’s year-to-date return of 26.05% significantly outpaces the Sensex’s negative 13.72% over the same period, underscoring its relative strength amid broader market weakness.

Read full news article

Emcure Pharmaceuticals Ltd is Rated Hold

2026-05-31 10:10:42

Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Emcure Pharmaceuticals Ltd Valuation Shifts Amidst Market Volatility

2026-05-25 08:02:02

Emcure Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, reflecting a recalibration of price attractiveness despite robust financial performance and market returns. This adjustment, coupled with a downgrade in its Mojo Grade from Buy to Hold, invites a closer examination of the company’s current market standing relative to its historical averages and peer group.

Read full news article

Emcure Pharmaceuticals Ltd is Rated Hold

2026-05-20 10:10:56

Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Emcure Pharmaceuticals Ltd Valuation Shifts Signal Caution Amid Strong Returns

2026-05-19 08:03:05

Emcure Pharmaceuticals Ltd has experienced a notable change in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, prompting a reassessment of its price attractiveness amid sector peers and historical benchmarks. Despite strong operational metrics, the stock’s elevated price-to-earnings and price-to-book ratios suggest a cautious stance for investors evaluating entry or exit points.

Read full news article

Emcure Pharmaceuticals Ltd Valuation Shifts Amid Market Volatility

2026-05-13 08:02:02

Emcure Pharmaceuticals Ltd has seen a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, despite delivering robust returns well above the Sensex benchmark. This recalibration in price attractiveness, driven by elevated price-to-earnings and price-to-book ratios, signals a critical juncture for investors assessing the stock’s future potential within the Pharmaceuticals & Biotechnology sector.

Read full news article

Emcure Pharmaceuticals Ltd is Rated Hold

2026-05-09 10:10:36

Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date view of its performance and prospects.

Read full news article

View All News